1. Anderson KM, Liao S (1968) Selective retention of dihydrotestosterone by prostatic nuclei. Nature (London) 219: 277–279
2. Barrack ER, Peters CA, Schulze H (1988) Localization of androgen receptors and estrogen receptors in the prostate. In: Sheridan PJ, Blum K, Trachtenberg MC (eds) Steroid receptors and disease. Cancer, autoimmune, bone, and circulatory disorders. Marcel Dekker, New York Basel, pp 329–368
3. Barrack ER, Tindall DJ (1987) A critical evaluation of the use of androgen receptor assays to predict the androgen responsiveness of prostatic cancer. In: Coffey DS, Bruchovsky N, Gardner WA, Resnick MJ, Karr JP (eds) Current concepts and approaches to the study of prostate cancer. Alan R Liss, New York, pp 155–187
4. Bartsch G, Keen F, Daxenbichler G, Marth CH, Margreiter R, Brüngger A, Sutter T, Rohr HP (1987) Correlation of biochemical (receptors, endogenous tissue hormones) and quantitative morphologic (stereologic) findings in normal and hyperplastic human prostates. J Urol 137: 559–564
5. Bartsch G, Rohr HP (1983) Androgen levels and binding in benign prostatic hyperplasia. In: Hinman F (ed) Benign prostatic hypertrophy. Springer, New York Heidelberg Berlin, pp 235–247